Oncogene - Table of Contents alert Volume 32 Issue 17

Advertisement Finally! Antibodies for ChIP and ChIP-seq that you can trust. Diagenode has revolutionized immunoprecipitation with a novel, rigorous antibody classification system. Since 2003, we are the only company to have worked closely with experts in the epigenetics community and well-known consortiums to develop the absolute best epigenetics reagents and antibodies. Have confidence in the antibodies you choose. Achieve unparalleled ChIP and ChIP-seq results with antibodies you can trust. Learn more. TABLE OF CONTENTS Volume 32, Issue 17 (April 2013) In this issue Review Original Articles Short Communication Also new AOP Advertisement NPG and Frontiers form alliance to further open science Frontiers is at the forefront of building the ultimate Open Science platform and is driving innovations around peer-review, article and author impact metrics and social networking for researchers. NPG and Frontiers will work together to empower researchers to change the way science is communicated. Find out more Sign up for e-alerts Recommend to your library Web feed Subscribe Review Top The RUNX family in breast cancer: relationships with estrogen signaling N-O Chimge and B Frenkel Oncogene 2013 32: 2121-2130; advance online publication, October 8, 2012; 10.1038/onc.2012.328 Abstract | Full Text Original Articles Top Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion S M Jafarnejad, G S Ardekani, M Ghaffari, M Martinka and G Li Oncogene 2013 32: 2131-2139; advance online publication, June 11, 2012; 10.1038/onc.2012.239 Abstract | Full Text FHL1 on chromosome X is a single-hit gastrointestinal tumor-suppressor gene and contributes to the formation of an epigenetic field defect K Asada, T Ando, T Niwa, S Nanjo, N Watanabe, E Okochi-Takada, T Yoshida, K Miyamoto, S Enomoto, M Ichinose, T Tsukamoto, S Ito, M Tatematsu, T Sugiyama and T Ushijima Oncogene 2013 32: 2140-2149; advance online publication, June 11, 2012; 10.1038/onc.2012.228 Abstract | Full Text The p53 isoform, Δ133p53α, stimulates angiogenesis and tumour progression H Bernard, B Garmy-Susini, N Ainaoui, L Van Den Berghe, A Peurichard, S Javerzat, A Bikfalvi, D P Lane, J C Bourdon and A-C Prats Oncogene 2013 32: 2150-2160; advance online publication, June 25, 2012; 10.1038/onc.2012.242 Abstract | Full Text ZRF1 controls oncogene-induced senescence through the INK4-ARF locus J D Ribeiro, L Morey, A Mas, A Gutierrez, N M Luis, S Mejetta, H Richly, S A Benitah, W M Keyes and L Di Croce Oncogene 2013 32: 2161-2168; advance online publication, June 25, 2012; 10.1038/onc.2012.241 Abstract | Full Text MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability E Xu, J Zhang and X Chen Oncogene 2013 32: 2169-2178; advance online publication, June 18, 2012; 10.1038/onc.2012.238 Abstract | Full Text Targeting the eIF4A RNA helicase blocks translation of the MUC1-C oncoprotein C Jin, H Rajabi, C M Rodrigo, J A Porco, Jr and D Kufe Oncogene 2013 32: 2179-2188; advance online publication, June 11, 2012; 10.1038/onc.2012.236 Abstract | Full Text GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase B Pérez-Benavente, J L García, M S Rodríguez, A Pineda-Lucena, M Piechaczyk, J Font de Mora and R Farràs Oncogene 2013 32: 2189-2199; advance online publication, June 18, 2012; 10.1038/onc.2012.235 Abstract | Full Text Loss of PTEN induces microtentacles through PI3K-independent activation of cofilin M I Vitolo, A E Boggs, R A Whipple, J R Yoon, K Thompson, M A Matrone, E H Cho, E M Balzer and S S Martin Oncogene 2013 32: 2200-2210; advance online publication, June 11, 2012; 10.1038/onc.2012.234 Abstract | Full Text Cooperation between p53 and the telomere-protecting shelterin component Pot1a in endometrial carcinogenesis Open E A Akbay, C G Peña, D Ruder, J A Michel, Y Nakada, S Pathak, A S Multani, S Chang and D H Castrillon Oncogene 2013 32: 2211-2219; advance online publication, June 11, 2012; 10.1038/onc.2012.232 Abstract | Full Text YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14 J-M Huang, I Nagatomo, E Suzuki, T Mizuno, T Kumagai, A Berezov, H Zhang, B Karlan, M I Greene and Q Wang Oncogene 2013 32: 2220-2229; advance online publication, June 11, 2012; 10.1038/onc.2012.231 Abstract | Full Text Beta-catenin inhibits melanocyte migration but induces melanoma metastasis S J Gallagher, F Rambow, M Kumasaka, D Champeval, A Bellacosa, V Delmas and L Larue Oncogene 2013 32: 2230-2238; advance online publication, June 4, 2012; 10.1038/onc.2012.229 Abstract | Full Text Short Communication Top MYC antagonizes the differentiation induced by imatinib in chronic myeloid leukemia cells through downregulation of p27KIP1 M T Gómez-Casares, E García-Alegria, C E López-Jorge, N Ferrándiz, R Blanco, S Alvarez, J P Vaqué, G Bretones, J M Caraballo, P Sánchez-Bailón, M D Delgado, J Martín-Perez, J C Cigudosa and J León Oncogene 2013 32: 2239-2246; advance online publication, June 18, 2012; 10.1038/onc.2012.246 Abstract | Full Text Advertisement Are you receiving the Genes & Immunity alert? 70,000 of your colleagues are. Sign up to stay up to date on the latest researching published in Genes & Immunity and never miss an article! G&I is dedicated to functional genetics of the immune response and increasing our understanding of how control over the immune system varies between individuals both in health and disease.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.